Richard Stewart
2020
In 2020, Richard Stewart earned a total compensation of $1M as Executive Chairman and Former Chief Executive Officer at OncoGenex Pharmaceuticals, a 30% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,630 |
|---|---|
| Option Awards | $333,029 |
| Salary | $473,846 |
| Total | $1,032,505 |
Stewart received $473.8K in salary, accounting for 46% of the total pay in 2020.
Stewart also received $225.6K in non-equity incentive plan and $333K in option awards.
Rankings
In 2020, Richard Stewart's compensation ranked 8,495th out of 13,090 executives tracked by ExecPay. In other words, Stewart earned more than 35.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,495 out of 13,090 | 35th |
Division Manufacturing | 3,614 out of 5,621 | 36th |
Major group Chemicals And Allied Products | 1,461 out of 2,254 | 35th |
Industry group Drugs | 1,272 out of 1,954 | 35th |
Industry In Vitro and In Vivo Diagnostic Substances | 31 out of 60 | 48th |
Source: SEC filing on March 30, 2021.
Stewart's colleagues
We found two more compensation records of executives who worked with Richard Stewart at OncoGenex Pharmaceuticals in 2020.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019